TXN and pulmonary arterial hypertension: In addition, we observed a decrease in the H2O2-reducing enzymes, catalase, and thioredoxin in PAH-hPASMCs compared with control hPASMCs, where effects on catalase were further reduced in 16αOHE1-treated PAH-hPASMCs.